1. Home
  2. CULP vs SER Comparison

CULP vs SER Comparison

Compare CULP & SER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Culp Inc.

CULP

Culp Inc.

HOLD

Current Price

$3.63

Market Cap

52.7M

ML Signal

HOLD

Logo Serina Therapeutics Inc.

SER

Serina Therapeutics Inc.

HOLD

Current Price

$2.92

Market Cap

42.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CULP
SER
Founded
1972
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Textiles
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
52.7M
42.0M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
CULP
SER
Price
$3.63
$2.92
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$13.00
AVG Volume (30 Days)
38.7K
15.1K
Earning Date
12-10-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$204,919,000.00
$116,000.00
Revenue This Year
$1.93
$134.46
Revenue Next Year
$2.77
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.42
$3.12
52 Week High
$5.94
$7.92

Technical Indicators

Market Signals
Indicator
CULP
SER
Relative Strength Index (RSI) 36.34 26.45
Support Level $3.60 $3.15
Resistance Level $3.82 $4.26
Average True Range (ATR) 0.15 0.23
MACD -0.01 -0.03
Stochastic Oscillator 5.26 1.47

Price Performance

Historical Comparison
CULP
SER

About CULP Culp Inc.

Culp Inc manufactures, markets mattress fabrics for bedding and upholstery fabrics for residential, commercial, and hospitality furnishings. The company has two operating segments: Mattress fabrics, which generate maximum revenue, and Upholstery fabrics. The mattress fabrics segment manufactures, sources, and sells fabrics and mattress covers to bedding manufacturers. The upholstery fabrics segment develops, sources, manufactures, and sells fabrics to residential, commercial, and hospitality furniture manufacturers. Geographically, it derives key revenue from the United States of America.

About SER Serina Therapeutics Inc.

Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The Company has one reportable segment relating to the research and development of its POZ platform.

Share on Social Networks: